Posted by Tyrone Williams on Feb 13th, 2026
Medpace (NASDAQ:MEDP) executives said elevated cancellations in the fourth quarter weighed on net bookings, but emphasized that underlying demand remained “adequate and headed in the right direction” as the contract research organization...
More of this article »